## NUE: Nucor Corporation - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 1.7% below STRENGTH zone (3.0-6.0%); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($152.87)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Russell Investments Group Ltd. Has $16.54 Million Stock Position in Nucor Corporation $NUE**
- Source: MarketBeat | 20251202T112222 | Somewhat-Bullish | Relevance: 100%
- Russell Investments Group Ltd. significantly reduced its stake in Nucor Corporation, selling 181,355 shares, but still holds 127,551 shares valued at $16.54 million. Nucor has outperformed Q3 expectations with strong EPS and revenue growth, leading to analyst upgrades and a "Moderate Buy" consensus rating. Despite some insider selling, institutional ownership remains high, with major firms like Vanguard and Nuveen holding substantial positions.

**2. Nucor (NYSE: NUE) raises dividend to $0.56, marking 211 consecutive payouts**
- Source: Stock Titan | 20251201T205100 | Bullish | Relevance: 99%
- Nucor (NYSE: NUE) announced an increase in its regular quarterly cash dividend to $0.56 per share, marking its 211th consecutive quarterly cash dividend. The dividend is payable on February 11, 2026, to stockholders of record on December 31, 2025. This increase continues Nucor's streak of raising its base dividend for 53 consecutive years, dating back to 1973.

**3. Quadrant Capital Group LLC Buys 2,189 Shares of Nucor Corporation $NUE**
- Source: MarketBeat | 20251201T110140 | Somewhat-Bullish | Relevance: 99%
- Quadrant Capital Group LLC increased its stake in Nucor Corporation by 26.1% in Q2, acquiring an additional 2,189 shares to hold a total of 10,564 shares valued at $1.37 million. Nucor surpassed Q3 earnings expectations, reporting an EPS of $2.63 against an estimated $2.30 and revenue of $8.52 billion, leading several analysts to raise their price targets and maintain a "Moderate Buy" consensus with a $167.20 target. Despite institutional accumulation, insiders have been net sellers, with the CFO and an EVP selling 18,045 shares totaling $2.72 million over the past three months.

**4. Greenwich Wealth Management LLC Buys Shares of 950,630 Nucor Corporation $NUE**
- Source: MarketBeat | 20251201T095246 | Bullish | Relevance: 99%
- Greenwich Wealth Management LLC acquired 950,630 shares of Nucor Corporation (NYSE: NUE) in Q2, making it their fourth-largest holding valuing approximately $123.1 million. This investment represents 0.41% ownership of Nucor, reflecting a bullish sentiment from institutional investors. The article highlights Nucor's strong financial performance, recent dividend announcement, and positive analyst ratings, with a consensus "Moderate Buy" and a price target of $167.20.

**5. Wealthquest Corp Purchases Shares of 2,586 Nucor Corporation $NUE**
- Source: MarketBeat | 20251130T134122 | Bullish | Relevance: 99%
- Wealthquest Corp recently acquired a new stake of 2,586 Nucor Corporation (NYSE:NUE) shares, valued at approximately $335,000, during the second quarter. This accumulation of shares occurred despite insider selling activity totaling $2.72 million over the past three months. Nucor has also reported strong quarterly earnings, beating analyst estimates, and has received a "Moderate Buy" consensus rating from analysts with an average target price of $167.20.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Jefferies | $190 | $170 | +12% |
| 2025-12-05 | JP Morgan | $200 | $175 | +14% |
| 2025-11-14 | Wells Fargo | $167 | $147 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Jefferies | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-14 | Wells Fargo | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($2.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-3.1%)
- State Farm Mutual Au: 10.6% (-0.7%)
- Blackrock Inc.: 8.1% (-3.6%)
- State Street Corpora: 5.3% (-2.7%)
- Berkshire Hathaway, : 2.8% (-3.1%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +13%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.75 indicates undervaluation relative to growth. Forward P/E 14.0x attractive for 42% earnings growth. Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (3 raises, avg +13%). Insider selling cluster ($2.1M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.6B |
| Beta | 1.86 |
| 52W Range | $97.59 - $166.27 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.75 |
| Forward P/E | 14.0 |
| Current P/E | 19.9 |
| YoY Growth | 42.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.9% to 1.7% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.3pp (needs >3.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.16), confirming momentum. RSI overbought at 72, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.66% (CS: 83) | Neutral |
| RSI_14 | 72.4 | Overbought |
| MACD Histogram | 1.16 | Bullish |
| vs SMA20 | 1.073x | Above |
| vs SMA50 | 1.122x | Above |
| vs SMA200 | 1.211x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $161.09
- **Stop Loss:** $152.87 (5.1% risk)
- **Target:** $169.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 121
- **Position Value:** $19,491.89
- **Portfolio %:** 19.49%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-26 (Est: $2.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.63 | +22.0% |
| 2025Q2 | $2.61 | $2.60 | -0.6% |
| 2025Q1 | $0.61 | $0.67 | +9.8% |
| 2024Q4 | $0.64 | $1.22 | +90.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*